Home/Filings/4/0001931826-22-000002
4//SEC Filing

Chen Robert C J 4

Accession 0001931826-22-000002

CIK 0001053369other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:53 PM ET

Size

5.5 KB

Accession

0001931826-22-000002

Insider Transaction Report

Form 4
Period: 2022-05-16
Chen Robert C J
CFO, Secretary, Treasurer
Transactions
  • Award

    Options

    2022-05-16$0.04/sh+900,000$36,000900,000 total
    Exercise: $0.04From: 2023-05-16Exp: 2032-05-16Common Stock (900,000 underlying)
Footnotes (2)
  • [F1]Options were awarded by the Board of Directions as part of Mr. Chen's employment agreement.
  • [F2]The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on May 16, 2023.

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeother

Related Parties

1
  • filerCIK 0001931826

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:53 PM ET
Size
5.5 KB